Albert Vendrell-Munoz

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache
Published: June 19, 2026

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Journal: Cephalalgia : an international journal of headache
Published: June 05, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology
Published: May 27, 2026

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Journal: Journal of neurology
Published: April 28, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology
Published: January 28, 2026

Linear Accelerator Mask-Based Radiosurgery for Trigeminal Neuralgia: Prospective Evaluation of 50 Patients.

Linear Accelerator Mask-Based Radiosurgery for Trigeminal Neuralgia: Prospective Evaluation of 50 Patients.

Journal: World neurosurgery
Published: January 27, 2026

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

Journal: The journal of headache and pain
Published: October 31, 2025

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

Journal: Headache
Published: September 06, 2025

Authors' response to comment on "Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen".

Authors' response to comment on "Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen".

Journal: Headache
Published: July 20, 2025

The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis.

The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis.

Journal: Multiple sclerosis and related disorders
Published: June 26, 2025

False nonresponders to anti-calcitonin gene-related peptide monoclonal antibodies: A real-world analysis beyond migraine frequency reduction.

False nonresponders to anti-calcitonin gene-related peptide monoclonal antibodies: A real-world analysis beyond migraine frequency reduction.

Journal: Headache
Published: June 12, 2025

Benign multiple sclerosis and long-term outcomes after 30 years.

Benign multiple sclerosis and long-term outcomes after 30 years.

Journal: Journal of neurology
Published: May 28, 2025
Showing 1-12 of 34

Last Updated: 09/26/2026